SENOKOT

This brand name is authorized in Australia, Ecuador, Hong Kong SAR China, Ireland, Mexico, New Zealand, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug SENOKOT contains one active pharmaceutical ingredient (API):

1	Sennosides UNII 3FYP5M0IJX - SENNOSIDES
	The sugar moiety of the sennosides is removed by bacteria in the large intestine releasing the active anthrone fraction. This stimulates peristalsis via the submucosal and myenteric nerve plexuses.
	Read more about Sennosides

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SENOKOT Syrup	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AB06	Senna glycosides	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives
Discover more medicines within A06AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	4455L
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	02096-MAE-12-03
GB	Medicines & Healthcare Products Regulatory Agency	102688, 154425, 33879, 33883, 387142, 387518, 388718, 45518, 95504, 95540
HK	Department of Health Drug Office	56454
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	093M91, 51727
NZ	Medicines and Medical Devices Safety Authority	105
SG	Health Sciences Authority	04731P
TR	İlaç ve Tıbbi Cihaz Kurumu	8690570015508, 8699543010427
ZA	Health Products Regulatory Authority	28/11.5/0644, A40/11.5/0050, E/11.5/671